Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TNXP
TNXP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TNXP News
Tonmya Receives FDA Approval, New Option for Fibromyalgia Treatment
3d ago
stocktwits
Tonix Pharmaceuticals Secures Coverage for Tonmya with GPO Agreement
3d ago
seekingalpha
Tonix Pharmaceuticals Reports Wider Q1 Loss and Revenue Decline
May 02 2026
stocktwits
TNXP Shares Plummet for Four Consecutive Days as Investors Anticipate Drug Pipeline Returns
Mar 27 2026
stocktwits
Life Sciences Virtual Investor Forum Highlights Available On-Demand
Mar 13 2026
Globenewswire
Tonix Pharmaceuticals Reports Strong Q4 Results with Nearly Doubling Sales
Mar 13 2026
Benzinga
Tonix Pharmaceuticals Reports Q4 Loss Amid Early Drug Adoption
Mar 13 2026
stocktwits
Tonix Pharmaceuticals Q4 Earnings Beat Expectations with Revenue Surge
Mar 12 2026
seekingalpha
Tonix Pharmaceuticals Reports Q4 Net Loss of $46.91 Million
Mar 12 2026
moomoo
Life Sciences Virtual Investor Forum Agenda Announced
Mar 10 2026
Globenewswire
TONMYA Launches as New Treatment for Fibromyalgia
Mar 09 2026
Newsfilter
TONMYA Receives FDA Approval for Fibromyalgia Treatment
Mar 05 2026
Newsfilter
Tonix Pharmaceuticals to Present Tonmya at AAPM Annual Meeting
Mar 03 2026
Newsfilter
Tonix Pharmaceuticals Shares Decline Post Nasdaq Uplisting
Mar 03 2026
Benzinga
Tonix Pharmaceuticals Successfully Uplists to Nasdaq Global Select Market
Mar 03 2026
Globenewswire
Tonix Pharmaceuticals Successfully Uplists to Nasdaq Global Select Market
Mar 03 2026
Newsfilter
Show More News
